Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats.

Saved in:
Bibliographic Details
Title: Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats.
Authors: Song D; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States., Crouse B; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.; School of Veterinary Population Medicine, University of Minnesota, St. Paul, Minnesota 55455, United States., Vigliaturo J; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States., Wu MM; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.; School of Veterinary Population Medicine, University of Minnesota, St. Paul, Minnesota 55455, United States., Heimisdottir D; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States., Kassick AJ; Neuroscience Disruptive Research Lab, Allegheny Health Network Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States., Averick SE; Neuroscience Disruptive Research Lab, Allegheny Health Network Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States.; Neuroscience Institute, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, United States., Raleigh MD; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States., Pravetoni M; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98195, United States.; University of Washington Center for Medication Development for Substance Use Disorders; Garvey Institute for Brain Solutions, Seattle,Washington 98195, United States.
Source: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2023 Dec 22; Vol. 7 (2), pp. 363-374. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2575-9108
DOI:10.1021/acsptsci.3c00228